| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | mitotic spindle | 4.74e-06 | 201 | 130 | 9 | GO:0072686 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SEL1L SEC16B MBTPS1 TMED6 SLC37A3 SLC43A1 HLA-DRB4 SGPP2 EXTL3 EDA GBA2 MBOAT2 TMEM174 RAB18 UBXN7 OSBPL6 LRBA HAS2 PLOD1 | 4.05e-04 | 1293 | 130 | 19 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SEL1L SEC16B MBTPS1 TMED6 SLC37A3 SLC43A1 HLA-DRB4 SGPP2 EXTL3 EDA GBA2 MBOAT2 TMEM174 RAB18 UBXN7 OSBPL6 LRBA HAS2 PLOD1 | 4.29e-04 | 1299 | 130 | 19 | GO:0098827 |
| GeneOntologyCellularComponent | lysosome | LAPTM4A SLC37A3 HLA-DRB4 CP NCF2 RNASEK TPCN1 USP6 CLTC LRP1 LRBA HAS2 CTSZ MCOLN2 | 5.31e-04 | 811 | 130 | 14 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | LAPTM4A SLC37A3 HLA-DRB4 CP NCF2 RNASEK TPCN1 USP6 CLTC LRP1 LRBA HAS2 CTSZ MCOLN2 | 5.31e-04 | 811 | 130 | 14 | GO:0000323 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SEL1L SEC16B MBTPS1 TMED6 SLC37A3 SLC43A1 HLA-DRB4 SGPP2 EXTL3 EDA GBA2 MBOAT2 TMEM174 RAB18 UBXN7 OSBPL6 LRBA HAS2 PLOD1 | 5.57e-04 | 1327 | 130 | 19 | GO:0042175 |
| GeneOntologyCellularComponent | lysosomal membrane | LAPTM4A SLC37A3 HLA-DRB4 CP RNASEK TPCN1 CLTC LRP1 LRBA MCOLN2 | 6.34e-04 | 462 | 130 | 10 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | LAPTM4A SLC37A3 HLA-DRB4 CP RNASEK TPCN1 CLTC LRP1 LRBA MCOLN2 | 6.34e-04 | 462 | 130 | 10 | GO:0098852 |
| MousePheno | decreased somite size | 2.24e-06 | 28 | 109 | 5 | MP:0011732 | |
| MousePheno | abnormal somite size | 8.17e-06 | 36 | 109 | 5 | MP:0005222 | |
| Domain | Beta-tubulin_BS | 3.82e-05 | 10 | 130 | 3 | IPR013838 | |
| Domain | Beta_tubulin | 3.82e-05 | 10 | 130 | 3 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 5.22e-05 | 11 | 130 | 3 | PS00228 | |
| Domain | Tox-GHH_dom | 2.86e-04 | 4 | 130 | 2 | IPR028916 | |
| Domain | Tox-GHH | 2.86e-04 | 4 | 130 | 2 | PF15636 | |
| Domain | Ten_N | 2.86e-04 | 4 | 130 | 2 | IPR009471 | |
| Domain | Ten_N | 2.86e-04 | 4 | 130 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.86e-04 | 4 | 130 | 2 | PS51361 | |
| Domain | - | 3.44e-04 | 20 | 130 | 3 | 3.30.1330.20 | |
| Domain | MFS_dom | 3.51e-04 | 134 | 130 | 6 | IPR020846 | |
| Domain | - | 4.00e-04 | 21 | 130 | 3 | 1.10.287.600 | |
| Domain | Tubulin_C | 4.61e-04 | 22 | 130 | 3 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 4.61e-04 | 22 | 130 | 3 | IPR018316 | |
| Domain | Cupredoxin | 4.61e-04 | 22 | 130 | 3 | IPR008972 | |
| Domain | - | 4.61e-04 | 22 | 130 | 3 | 3.40.50.1440 | |
| Domain | Tubulin_C | 4.61e-04 | 22 | 130 | 3 | SM00865 | |
| Domain | YD | 4.74e-04 | 5 | 130 | 2 | IPR006530 | |
| Domain | TPR_8 | 5.04e-04 | 53 | 130 | 4 | PF13181 | |
| Domain | Tub_FtsZ_C | 5.27e-04 | 23 | 130 | 3 | IPR008280 | |
| Domain | Tubulin_C | 5.27e-04 | 23 | 130 | 3 | IPR023123 | |
| Domain | TUBULIN | 5.27e-04 | 23 | 130 | 3 | PS00227 | |
| Domain | Tubulin | 5.27e-04 | 23 | 130 | 3 | IPR000217 | |
| Domain | Tubulin | 5.27e-04 | 23 | 130 | 3 | SM00864 | |
| Domain | Tubulin_CS | 5.27e-04 | 23 | 130 | 3 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 5.99e-04 | 24 | 130 | 3 | IPR003008 | |
| Domain | Tubulin | 5.99e-04 | 24 | 130 | 3 | PF00091 | |
| Domain | TPR-like_helical_dom | 1.24e-03 | 233 | 130 | 7 | IPR011990 | |
| Domain | - | 2.51e-03 | 39 | 130 | 3 | 2.120.10.30 | |
| Domain | OA_transporter | 3.03e-03 | 12 | 130 | 2 | IPR004156 | |
| Domain | OATP | 3.03e-03 | 12 | 130 | 2 | PF03137 | |
| Domain | - | 3.30e-03 | 207 | 130 | 6 | 1.25.40.10 | |
| Domain | Nucleotide-diphossugar_trans | 3.33e-03 | 88 | 130 | 4 | IPR029044 | |
| Domain | OLF | 3.57e-03 | 13 | 130 | 2 | PF02191 | |
| Domain | OLF | 3.57e-03 | 13 | 130 | 2 | PS51132 | |
| Domain | - | 3.57e-03 | 13 | 130 | 2 | 2.10.10.10 | |
| Domain | NHL | 3.57e-03 | 13 | 130 | 2 | PS51125 | |
| Domain | Olfac-like_dom | 3.57e-03 | 13 | 130 | 2 | IPR003112 | |
| Domain | OLF | 3.57e-03 | 13 | 130 | 2 | SM00284 | |
| Domain | TPR_1 | 3.61e-03 | 90 | 130 | 4 | IPR001440 | |
| Domain | TPR_1 | 3.61e-03 | 90 | 130 | 4 | PF00515 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.02e-03 | 46 | 130 | 3 | IPR011042 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.14e-03 | 14 | 130 | 2 | IPR024317 | |
| Domain | FN_type2_col-bd | 4.14e-03 | 14 | 130 | 2 | IPR000562 | |
| Domain | FN2_2 | 4.14e-03 | 14 | 130 | 2 | PS51092 | |
| Domain | Dynein_HC_stalk | 4.14e-03 | 14 | 130 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.14e-03 | 14 | 130 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.14e-03 | 14 | 130 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.14e-03 | 14 | 130 | 2 | IPR011704 | |
| Domain | FN2_1 | 4.14e-03 | 14 | 130 | 2 | PS00023 | |
| Domain | MT | 4.14e-03 | 14 | 130 | 2 | PF12777 | |
| Domain | AAA_8 | 4.14e-03 | 14 | 130 | 2 | PF12780 | |
| Domain | fn2 | 4.14e-03 | 14 | 130 | 2 | PF00040 | |
| Domain | FN2 | 4.14e-03 | 14 | 130 | 2 | SM00059 | |
| Domain | AAA_5 | 4.14e-03 | 14 | 130 | 2 | PF07728 | |
| Domain | DHC_fam | 4.76e-03 | 15 | 130 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.76e-03 | 15 | 130 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.76e-03 | 15 | 130 | 2 | IPR004273 | |
| Domain | TNF_1 | 6.11e-03 | 17 | 130 | 2 | PS00251 | |
| Domain | Peptidase_aspartic_dom | 6.11e-03 | 17 | 130 | 2 | IPR021109 | |
| Domain | TNF | 6.84e-03 | 18 | 130 | 2 | SM00207 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.39e-05 | 43 | 102 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.74e-05 | 45 | 102 | 5 | M47670 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 2.06e-05 | 23 | 102 | 4 | M47900 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 2.32e-04 | 17 | 102 | 3 | M47768 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SEL1L MBTPS1 ABCA12 ATP8A2 SLC43A1 TRPC5 SLCO3A1 CP SLCO1B1 TPCN1 MLKL SLC15A1 CLTC STEAP3 MCOLN2 | 2.54e-04 | 736 | 102 | 15 | M27287 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.77e-04 | 18 | 102 | 3 | M47753 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.02e-04 | 126 | 102 | 6 | M705 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.28e-04 | 19 | 102 | 3 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.28e-04 | 19 | 102 | 3 | M47813 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SEL1L ABCA12 ATP8A2 SLC43A1 TRPC5 SLCO3A1 CP SLCO1B1 TPCN1 MLKL SLC15A1 CLTC STEAP3 MCOLN2 | 3.81e-04 | 681 | 102 | 14 | MM14985 |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 3.83e-04 | 20 | 102 | 3 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 3.83e-04 | 20 | 102 | 3 | M47911 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 4.26e-04 | 49 | 102 | 4 | M891 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.45e-04 | 21 | 102 | 3 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.45e-04 | 21 | 102 | 3 | M47767 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.97e-04 | 51 | 102 | 4 | M26972 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 5.12e-04 | 22 | 102 | 3 | M47903 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 5.76e-04 | 53 | 102 | 4 | M27651 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 5.86e-04 | 23 | 102 | 3 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 6.67e-04 | 24 | 102 | 3 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.67e-04 | 24 | 102 | 3 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 7.53e-04 | 25 | 102 | 3 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.53e-04 | 25 | 102 | 3 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.47e-04 | 26 | 102 | 3 | M47672 | |
| Pathway | REACTOME_KINESINS | 9.83e-04 | 61 | 102 | 4 | M977 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.06e-03 | 28 | 102 | 3 | M47898 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.06e-03 | 28 | 102 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.06e-03 | 28 | 102 | 3 | M27241 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT | 1.06e-03 | 7 | 102 | 2 | M47925 | |
| Pubmed | 6.70e-09 | 105 | 131 | 8 | 9628581 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L USP34 MBTPS1 ITGA11 UGGT1 RNF149 EXTL3 GCNT1 MBOAT2 YWHAG TXNDC12 TPCN1 SLC6A8 OLFML2A IGF2R TENM3 LRP1 TOR1B PLOD1 CTSZ | 2.59e-08 | 1201 | 131 | 20 | 35696571 |
| Pubmed | SEL1L KIF23 NCKAP1 AKAP17A PEG10 UGGT1 RNF149 STARD7 YWHAG NDUFV1 TXNDC12 RAB18 IGF2R CLTC SORBS3 TOR1B CDC27 PLOD1 CTSZ AQR | 9.03e-08 | 1297 | 131 | 20 | 33545068 | |
| Pubmed | MBTPS1 TTC28 NCKAP1 PPRC1 IGDCC4 TENM3 PCDH19 CLTC PACS2 PCDH10 AQR | 4.45e-07 | 407 | 131 | 11 | 12693553 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | USP34 COA3 AKAP17A MYO9A HEATR4 SLCO3A1 EYS RAB18 ATF7IP2 LRP1 DNAH8 | 6.06e-07 | 420 | 131 | 11 | 28065597 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 SLC37A3 PPRC1 KAT2A EXTL3 GBA2 HIRA TPCN1 SLC6A8 URB1 IGF2R ARHGAP44 SORBS3 STEAP3 PLEC LRBA CTSZ | 9.45e-07 | 1105 | 131 | 17 | 35748872 |
| Pubmed | USP34 KIF23 NCKAP1 UGGT1 NUP205 TUBB4A URB1 DDX46 IGF2R CLTC PLEC PLOD1 AQR | 1.23e-06 | 653 | 131 | 13 | 22586326 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.33e-06 | 22 | 131 | 4 | 23826228 | |
| Pubmed | 1.45e-06 | 285 | 131 | 9 | 21423176 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SEL1L GPI USP34 NCKAP1 IQSEC2 RNF149 TXNDC12 NUP205 RAB18 IGF2R CLTC LRP1 STEAP3 TNKS PLEC PLOD1 AQR | 2.97e-06 | 1203 | 131 | 17 | 29180619 |
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 17302988 | ||
| Pubmed | 1.12e-05 | 12 | 131 | 3 | 24291790 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 21347226 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 15836428 | ||
| Pubmed | Prenylated Rab acceptor RABAC1 inhibits anti-apoptotic protein BCL2A1 and induces apoptosis. | 1.41e-05 | 2 | 131 | 2 | 31003775 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.45e-05 | 13 | 131 | 3 | 10908577 | |
| Pubmed | MBTPS1 SLC43A1 UGGT1 TRAPPC8 MBOAT2 NUP205 SLC6A8 TUBB4A RAB18 IGF2R CLTC STEAP3 LRBA PCDH10 | 1.52e-05 | 952 | 131 | 14 | 38569033 | |
| Pubmed | 1.84e-05 | 14 | 131 | 3 | 12486001 | ||
| Pubmed | SEL1L UGGT1 YWHAG NUP205 TUBB4A IGF2R CLTC LRP1 TOR1B PLOD1 CTSZ | 2.20e-05 | 613 | 131 | 11 | 22268729 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GPI ERCC5 NCKAP1 TUBB8 UGGT1 STARD7 YWHAG TXNDC12 MLKL RAB18 DDX46 CLTC C8orf82 PLEC PLOD1 CTSZ AQR | 2.44e-05 | 1415 | 131 | 17 | 28515276 |
| Pubmed | USP34 TTC28 AKAP17A PPRC1 PEG10 IQSEC2 UBA3 EXTL3 PRDM4 YWHAG TUBB4A CLTC LRP1 TNKS PLEC LRBA | 2.81e-05 | 1285 | 131 | 16 | 35914814 | |
| Pubmed | SEL1L LAPTM4A MBTPS1 PEG10 UGGT1 NCF2 GCNT1 NDUFV1 INPP4B HENMT1 RAB18 LTA TOR1B PLCG2 PLEC CDC27 | 3.03e-05 | 1293 | 131 | 16 | 15342556 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 3.22e-05 | 235 | 131 | 7 | 30258100 | |
| Pubmed | Differential requirements for Tousled-like kinases 1 and 2 in mammalian development. | 3.42e-05 | 17 | 131 | 3 | 28708136 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 3.96e-05 | 431 | 131 | 9 | 33660365 | |
| Pubmed | GPI USP34 TDRD15 KIF23 TTC28 PKHD1L1 IGF2R TENM3 CLTC STEAP3 LRBA PCDH10 | 3.99e-05 | 777 | 131 | 12 | 35844135 | |
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 4.09e-05 | 18 | 131 | 3 | 23696569 | |
| Pubmed | SEL1L GPI MBTPS1 KIF23 UBA3 MUC12 KAT2A PRDM4 NUP205 SLC6A8 RAB18 DDX46 PIK3CB CLTC GATAD1 ASF1A | 4.13e-05 | 1327 | 131 | 16 | 32694731 | |
| Pubmed | PDCD4 interacting with PIK3CB and CTSZ promotes the apoptosis of multiple myeloma cells. | 4.21e-05 | 3 | 131 | 2 | 39190024 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12928432 | ||
| Pubmed | Identification and characterization of three members of a novel subclass of protocadherins. | 4.21e-05 | 3 | 131 | 2 | 11549318 | |
| Pubmed | Molecular dissection of formation of senescence-associated heterochromatin foci. | 4.21e-05 | 3 | 131 | 2 | 17242207 | |
| Pubmed | SNX4 in complex with clathrin and dynein: implications for endosome movement. | 4.21e-05 | 3 | 131 | 2 | 19529763 | |
| Pubmed | In vivo study of the nucleosome assembly functions of ASF1 histone chaperones in human cells. | 4.21e-05 | 3 | 131 | 2 | 18378699 | |
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 4.36e-05 | 102 | 131 | 5 | 20508983 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | GPI UGGT1 CP DPP3 YWHAG DNAH1 TUBB4A RAB18 CLTC PACS2 PLEC LRBA | 5.73e-05 | 807 | 131 | 12 | 30575818 |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 7.63e-05 | 22 | 131 | 3 | 16526095 | |
| Pubmed | 7.63e-05 | 22 | 131 | 3 | 35245678 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 8.41e-05 | 4 | 131 | 2 | 10225957 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 8910533 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 22401310 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 15621527 | ||
| Pubmed | INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. | 8.41e-05 | 4 | 131 | 2 | 28196852 | |
| Pubmed | Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex. | 8.41e-05 | 4 | 131 | 2 | 21807893 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 16980972 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 21414300 | ||
| Pubmed | Genetic and age related models of neurodegeneration in mice: dystrophic axons. | 8.41e-05 | 4 | 131 | 2 | 1634998 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 8.41e-05 | 4 | 131 | 2 | 12000766 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 25658096 | ||
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 19029251 | ||
| Pubmed | 9.98e-05 | 24 | 131 | 3 | 20168089 | ||
| Pubmed | Electrophoretic variation for x-chromosome-linked phosphoglycerate kinase (pgk-1) in the mouse. | 1.40e-04 | 5 | 131 | 2 | 17248765 | |
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 2448136 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 10873595 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 3600793 | ||
| Pubmed | Aurora B and 14-3-3 coordinately regulate clustering of centralspindlin during cytokinesis. | 1.40e-04 | 5 | 131 | 2 | 20451386 | |
| Pubmed | The role of histone chaperones in osteoblastic differentiation of C2C12 myoblasts. | 1.40e-04 | 5 | 131 | 2 | 22705305 | |
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 2296595 | ||
| Pubmed | Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor. | 1.40e-04 | 5 | 131 | 2 | 11387476 | |
| Pubmed | Contact-dependent promotion of cell migration by the OL-protocadherin-Nap1 interaction. | 1.40e-04 | 5 | 131 | 2 | 18644894 | |
| Pubmed | SEL1L NCKAP1 AKAP17A TUBB8 PUSL1 KAT2A YWHAG NDUFV1 HIRA URB1 RAB18 DDX46 GATAD1 CDC27 ASF1A AQR | 1.67e-04 | 1497 | 131 | 16 | 31527615 | |
| Pubmed | DAXX-dependent supply of soluble (H3.3-H4) dimers to PML bodies pending deposition into chromatin. | 2.09e-04 | 6 | 131 | 2 | 23222847 | |
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 12163475 | ||
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 3782288 | ||
| Pubmed | Genome-wide association study of multiplex schizophrenia pedigrees. | 2.09e-04 | 6 | 131 | 2 | 22885689 | |
| Pubmed | X-linked and autosomal genes controlling mouse alpha-galactosidase expression. | 2.09e-04 | 6 | 131 | 2 | 205481 | |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 2.17e-04 | 31 | 131 | 3 | 19136429 | |
| Pubmed | 2.87e-04 | 34 | 131 | 3 | 32553152 | ||
| Pubmed | 2.92e-04 | 7 | 131 | 2 | 3243423 | ||
| Pubmed | 2.92e-04 | 7 | 131 | 2 | 9256245 | ||
| Pubmed | Transport of Iodothyronines by Human L-Type Amino Acid Transporters. | 2.92e-04 | 7 | 131 | 2 | 26305885 | |
| Pubmed | 2.92e-04 | 7 | 131 | 2 | 12915301 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 2.99e-04 | 564 | 131 | 9 | 21565611 | |
| Pubmed | Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | 3.51e-04 | 159 | 131 | 5 | 36762613 | |
| Pubmed | SEL1L USP34 KIF23 TUBB8 UGGT1 EXTL3 YWHAG HIRA NUP205 TUBB4A URB1 RAB18 DDX46 CLTC PLOD1 | 3.55e-04 | 1440 | 131 | 15 | 30833792 | |
| Pubmed | 3.60e-04 | 247 | 131 | 6 | 30713523 | ||
| Pubmed | 3.76e-04 | 249 | 131 | 6 | 30097533 | ||
| Pubmed | 3.88e-04 | 8 | 131 | 2 | 31659279 | ||
| Pubmed | 3.88e-04 | 8 | 131 | 2 | 10331952 | ||
| Pubmed | 3.88e-04 | 8 | 131 | 2 | 8632996 | ||
| Pubmed | Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. | 3.88e-04 | 8 | 131 | 2 | 19129463 | |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 3.88e-04 | 8 | 131 | 2 | 23246003 | |
| Pubmed | A Cul4 E3 ubiquitin ligase regulates histone hand-off during nucleosome assembly. | 3.88e-04 | 8 | 131 | 2 | 24209620 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 NCKAP1 TUBB8 PEG10 UGGT1 UBA3 DPP3 YWHAG NUP205 TUBB4A UBXN7 PLEC LRBA PLOD1 ASF1A | 3.96e-04 | 1455 | 131 | 15 | 22863883 |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 3.99e-04 | 91 | 131 | 4 | 28558017 | |
| Pubmed | 4.05e-04 | 164 | 131 | 5 | 32409323 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | TTC28 UBA3 DPP3 KAT2A NUP205 USP6 IGF2R LRP1 TNKS PLEC CDC27 AQR | 4.33e-04 | 1005 | 131 | 12 | 19615732 |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 4.69e-04 | 95 | 131 | 4 | 27129302 | |
| Pubmed | Transcriptional profiling of mESC-derived tendon and fibrocartilage cell fate switch. | 4.98e-04 | 9 | 131 | 2 | 34244516 | |
| Pubmed | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. | 5.01e-04 | 41 | 131 | 3 | 23676500 | |
| Pubmed | 5.35e-04 | 371 | 131 | 7 | 15747579 | ||
| Pubmed | 5.61e-04 | 374 | 131 | 7 | 23824909 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 5.65e-04 | 269 | 131 | 6 | 29511261 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.87e-04 | 271 | 131 | 6 | 32433965 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GPI KIF23 NCKAP1 MYO9A YWHAG HIRA NUP205 URB1 CLTC PLCG2 PLEC CDC27 PLOD1 AQR | 6.01e-04 | 1353 | 131 | 14 | 29467282 |
| Pubmed | Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. | 6.21e-04 | 10 | 131 | 2 | 26005850 | |
| Pubmed | CCBE1 Is Essential for Epicardial Function during Myocardium Development. | 6.21e-04 | 10 | 131 | 2 | 36293499 | |
| Pubmed | 6.21e-04 | 10 | 131 | 2 | 38713721 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GPI KIF23 NCKAP1 UGGT1 CP YWHAG NUP205 TUBB4A DDX46 IGF2R CLTC LRP1 CDC27 PLOD1 | 6.64e-04 | 1367 | 131 | 14 | 32687490 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GPI USP34 LAPTM4A PEG10 RNF149 EXTL3 NUP205 ALDH1A2 IGF2R STEAP3 TOR1B LRBA | 6.97e-04 | 1061 | 131 | 12 | 33845483 |
| GeneFamily | Tubulins | 3.45e-04 | 26 | 96 | 3 | 778 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP | 7.20e-06 | 198 | 131 | 8 | M5170 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.08e-05 | 276 | 131 | 9 | M3063 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP | 1.13e-05 | 151 | 131 | 7 | M6760 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.51e-05 | 158 | 131 | 7 | M9147 | |
| Coexpression | KONDO_EZH2_TARGETS | 2.07e-05 | 229 | 131 | 8 | M5301 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 6.60e-05 | 199 | 131 | 7 | M6264 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | 6.60e-05 | 199 | 131 | 7 | M5201 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP | 6.81e-05 | 200 | 131 | 7 | M9922 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 6.81e-05 | 200 | 131 | 7 | M6552 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-08 | 188 | 130 | 8 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-08 | 188 | 130 | 8 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-08 | 188 | 130 | 8 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-08 | 190 | 130 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 186 | 130 | 7 | cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 187 | 130 | 7 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 187 | 130 | 7 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 187 | 130 | 7 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 193 | 130 | 7 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 193 | 130 | 7 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-06 | 194 | 130 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.99e-06 | 199 | 130 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.99e-06 | 199 | 130 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-06 | 199 | 130 | 7 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.06e-06 | 200 | 130 | 7 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.79e-06 | 164 | 130 | 6 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-06 | 165 | 130 | 6 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 173 | 130 | 6 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 173 | 130 | 6 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-05 | 175 | 130 | 6 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-05 | 175 | 130 | 6 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.31e-05 | 176 | 130 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-05 | 177 | 130 | 6 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-05 | 177 | 130 | 6 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 178 | 130 | 6 | 63f5880a5b514e20ef2c07a6a9cb8df34e6cede5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 178 | 130 | 6 | 82c84f8b8a7e6a3d3be3351b348a37143279c100 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 178 | 130 | 6 | cb91558469ae0748106fb0b6d702edb0ff21a884 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-05 | 179 | 130 | 6 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 179 | 130 | 6 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 185 | 130 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | ff6ccfdf2509f96caa10281c29a95b432f6c6dcc | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | 6e6998f5ccb1b2628048a21e8d3053e020569aba | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.80e-05 | 186 | 130 | 6 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 187 | 130 | 6 | 71385068e3fd0bfa7822ae176113a49460c8636b | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-05 | 187 | 130 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 187 | 130 | 6 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 187 | 130 | 6 | b930d5f7d410ac1f340babec5c937388f64cafc0 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-05 | 187 | 130 | 6 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 187 | 130 | 6 | e891e571f6bb9433a0046215de6cabd89ed1effc | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 187 | 130 | 6 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 188 | 130 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 189 | 130 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 189 | 130 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 56f43e00d81cf3cdf0c39f8d7120f5beab72e258 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 190 | 130 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 191 | 130 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 191 | 130 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-05 | 192 | 130 | 6 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 192 | 130 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 192 | 130 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.15e-05 | 192 | 130 | 6 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 192 | 130 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-05 | 192 | 130 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 192 | 130 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.15e-05 | 192 | 130 | 6 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-05 | 192 | 130 | 6 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 193 | 130 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | 92048d2e9e43513e6185e09553be3ee47d7e5207 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | ac088c8f27b5b1888610e461ff45870ca60da886 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.21e-05 | 193 | 130 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-05 | 194 | 130 | 6 | ce0486ce43748ffe486f08fdddd1f6acbfcc6b0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 194 | 130 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.28e-05 | 194 | 130 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 194 | 130 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 195 | 130 | 6 | 19347b7e8d3ea67e0fddd948078abcab9d364a2d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 195 | 130 | 6 | 55b4030f078173b0136990fae87b6eaf44c58f33 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 195 | 130 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 195 | 130 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.41e-05 | 196 | 130 | 6 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-05 | 196 | 130 | 6 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | remission-Non-classical_Monocyte|remission / disease stage, cell group and cell class | 2.41e-05 | 196 | 130 | 6 | 049d995986c20ce066bd64fcc2d2f1c2f8899883 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 196 | 130 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 196 | 130 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | control-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.41e-05 | 196 | 130 | 6 | 10d914f1612622f64ac71da04e1995a854a4bec9 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-05 | 196 | 130 | 6 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-05 | 196 | 130 | 6 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 197 | 130 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 197 | 130 | 6 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 197 | 130 | 6 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 197 | 130 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.48e-05 | 197 | 130 | 6 | f807d8cd377ee58c02be7f71b39cd227f6b4f5df | |
| ToppCell | severe-Others-Megakaryocytes|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.48e-05 | 197 | 130 | 6 | fc0864e2de2d9f99084586b467551b6da535d933 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 197 | 130 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-05 | 198 | 130 | 6 | cbbdd44dfa95370c0fbaa65ba71d86bfee0ea379 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-05 | 198 | 130 | 6 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.55e-05 | 198 | 130 | 6 | 3bc3dbd178043deadd7eef413b2761dc003abd6e | |
| ToppCell | Healthy-Non-classical_Monocyte|Healthy / disease group, cell group and cell class | 2.55e-05 | 198 | 130 | 6 | 394e5fa8998c46c6f7cd57b53f347d2029c75ae1 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 198 | 130 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.55e-05 | 198 | 130 | 6 | 9b47585653aaebd033c9b7bba93c7a7c35a4d60e | |
| ToppCell | PBMC-Control-Myeloid-Non-classical_Monocyte-Non-classical_Monocyte|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.55e-05 | 198 | 130 | 6 | 8b5d30312bbcabc6911ff03e5028766d77203dff | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 1.68e-07 | 12 | 129 | 4 | DOID:0050997 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 9.58e-06 | 10 | 129 | 3 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 9.58e-06 | 10 | 129 | 3 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 9.58e-06 | 10 | 129 | 3 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 9.58e-06 | 10 | 129 | 3 | DOID:0090132 (implicated_via_orthology) | |
| Disease | 1-stearoyl-GPG (18:0) measurement | 1.90e-05 | 2 | 129 | 2 | EFO_0800228 | |
| Disease | 2-docosahexaenoyl-GPE (22:6) measurement | 1.90e-05 | 2 | 129 | 2 | EFO_0800297 | |
| Disease | 1-palmitoyl-GPG (16:0) measurement | 1.90e-05 | 2 | 129 | 2 | EFO_0800367 | |
| Disease | 1-oleoyl-GPE (18:1) measurement | 5.67e-05 | 3 | 129 | 2 | EFO_0800246 | |
| Disease | 2-linoleoyl-GPE (18:2) measurement | 1.13e-04 | 4 | 129 | 2 | EFO_0800264 | |
| Disease | 1-docosahexaenoyl-GPE (22:6) measurement | 1.13e-04 | 4 | 129 | 2 | EFO_0800296 | |
| Disease | level of Phosphatidylcholine (O-16:0_16:1) in blood serum | 1.88e-04 | 5 | 129 | 2 | OBA_2045112 | |
| Disease | lysophosphatidylethanolamine 22:6 measurement | 2.47e-04 | 28 | 129 | 3 | EFO_0010371 | |
| Disease | Mental Retardation, X-Linked | 2.74e-04 | 29 | 129 | 3 | C1136249 | |
| Disease | tetradecadienedioate (C14:2-DC) measurement | 2.81e-04 | 6 | 129 | 2 | EFO_0800585 | |
| Disease | intellectual disability (is_implicated_in) | 3.04e-04 | 30 | 129 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | octadecanedioylcarnitine (C18-DC) measurement | 3.93e-04 | 7 | 129 | 2 | EFO_0800371 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 4.80e-04 | 225 | 129 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 5.22e-04 | 8 | 129 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | 2-arachidonoyl-GPE (20:4) measurement | 5.22e-04 | 8 | 129 | 2 | EFO_0800260 | |
| Disease | 1-linoleoyl-GPE (18:2) measurement | 5.22e-04 | 8 | 129 | 2 | EFO_0800247 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 5.76e-04 | 153 | 129 | 5 | EFO_0004611, EFO_0020944 | |
| Disease | ceramide measurement | 6.03e-04 | 235 | 129 | 6 | EFO_0010222 | |
| Disease | heart disease (implicated_via_orthology) | 6.16e-04 | 38 | 129 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | 1-arachidonoyl-GPE (20:4n6) measurement | 6.69e-04 | 9 | 129 | 2 | EFO_0800248 | |
| Disease | X-17653 measurement | 6.69e-04 | 9 | 129 | 2 | EFO_0800783 | |
| Disease | triacylglycerol 54:1 measurement | 8.34e-04 | 10 | 129 | 2 | EFO_0010419 | |
| Disease | Malignant neoplasm of breast | GPI RNF149 BCL2A1 TRAPPC8 SLCO1B1 INPP4B SLC2A5 PIK3CB TENM1 DIO3 LRBA CDC27 PLOD1 | 8.74e-04 | 1074 | 129 | 13 | C0006142 |
| Disease | triglycerides in large LDL measurement | 8.87e-04 | 43 | 129 | 3 | EFO_0022319 | |
| Disease | X-11308 measurement | 1.02e-03 | 11 | 129 | 2 | EFO_0800693 | |
| Disease | Paranoia | 1.02e-03 | 11 | 129 | 2 | C1456784 | |
| Disease | psychosocial stress measurement | 1.02e-03 | 11 | 129 | 2 | EFO_0006783 | |
| Disease | triacylglycerol 54:4 measurement | 1.08e-03 | 46 | 129 | 3 | EFO_0010422 | |
| Disease | Hypoxanthine measurement | 1.43e-03 | 13 | 129 | 2 | EFO_0021604 | |
| Disease | total lipids in LDL measurement | 1.54e-03 | 52 | 129 | 3 | EFO_0022308 | |
| Disease | Liver carcinoma | 1.79e-03 | 507 | 129 | 8 | C2239176 | |
| Disease | triglycerides in LDL measurement | 1.91e-03 | 56 | 129 | 3 | EFO_0022320 | |
| Disease | low density lipoprotein triglyceride measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0009946 | |
| Disease | tumor necrosis factor measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0010834 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0010367 | |
| Disease | response to statin, LDL cholesterol change measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0007804, GO_0036273 | |
| Disease | X-17654 measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0800784 | |
| Disease | total lipids in large LDL | 2.01e-03 | 57 | 129 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 2.01e-03 | 57 | 129 | 3 | EFO_0021901 | |
| Disease | triglycerides in IDL measurement | 2.11e-03 | 58 | 129 | 3 | EFO_0022149 | |
| Disease | response to methotrexate | 2.19e-03 | 16 | 129 | 2 | GO_0031427 | |
| Disease | phospholipids in VLDL measurement | 2.22e-03 | 59 | 129 | 3 | EFO_0022301 | |
| Disease | total lipids in VLDL measurement | 2.33e-03 | 60 | 129 | 3 | EFO_0022314 | |
| Disease | free cholesterol in VLDL measurement | 2.44e-03 | 61 | 129 | 3 | EFO_0022276 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.47e-03 | 17 | 129 | 2 | EFO_0022232 | |
| Disease | triglycerides in medium LDL measurement | 2.56e-03 | 62 | 129 | 3 | EFO_0022322 | |
| Disease | platelet measurement | 2.68e-03 | 315 | 129 | 6 | EFO_0005036 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 2.77e-03 | 18 | 129 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | serum metabolite measurement | TDRD15 HEATR4 SGPP2 SLCO1B1 ALDH1A2 IGF2R TENM3 PAH EXOC6B PLCG2 CTSZ | 2.96e-03 | 945 | 129 | 11 | EFO_0005653 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.98e-03 | 222 | 129 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.10e-03 | 224 | 129 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | total lipids in small VLDL | 3.19e-03 | 67 | 129 | 3 | EFO_0022148 | |
| Disease | radiation-induced disorder | 3.19e-03 | 67 | 129 | 3 | EFO_0009565 | |
| Disease | triglycerides in very small VLDL measurement | 3.33e-03 | 68 | 129 | 3 | EFO_0022144 | |
| Disease | synophrys measurement | 3.33e-03 | 68 | 129 | 3 | EFO_0007906 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.47e-03 | 69 | 129 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 4.32e-03 | 150 | 129 | 4 | EFO_0004611, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALNYSVFYYEIQNAP | 176 | P61981 | |
| REYFYYVDHQGQLFL | 41 | Q6P1X6 | |
| EYVLLEVNGQFSYSY | 601 | Q86XM0 | |
| RLANYTGGIYAEYQD | 221 | Q9UBR2 | |
| LFYYNFQVRGVYSRS | 16 | Q6QNK2 | |
| FYVDLQGVIKTFRYY | 136 | O94788 | |
| FSYASQYIARYEEQG | 1216 | Q86UK0 | |
| YRGQEFIRVGYYVNN | 101 | Q9Y294 | |
| FIRVGYYVNNEYTET | 106 | Q9Y294 | |
| FGYIYRLAQDYLQCV | 6 | Q16548 | |
| YFYQNLGEAEYVVAL | 1196 | O60306 | |
| EQVANVVLYSSDYYV | 246 | P10523 | |
| DYLFVGNIVYTYVVV | 996 | Q9NTI2 | |
| NTDYEFYVVAYSQLG | 496 | Q8TDY8 | |
| SYYRGAQGVILVYDV | 76 | Q9NP72 | |
| ATDADEGYYAQVVYF | 266 | Q9Y5H1 | |
| LGQYQYERYGAVELS | 131 | P78412 | |
| NILYFLTYADEYAIG | 606 | Q92830 | |
| VVVSEYFYQEEFYIR | 376 | Q92621 | |
| TFYLGERTYYIAAVE | 726 | P00450 | |
| GQVVYSFYGYVNDRT | 271 | Q8TAB3 | |
| VRYYGDSYLEFQNVA | 1886 | Q5T1H1 | |
| TRVYIFDYGQYSADF | 116 | Q6ZWT7 | |
| AVAYFQRGMLYYQTE | 71 | P19878 | |
| FVAAAYYYGASRRAI | 461 | Q7RTR2 | |
| VVEYEYIVAFNGYFT | 51 | Q14703 | |
| SSAYGAYFERLYVIQ | 251 | P55073 | |
| NIQYEVIGNYYSSER | 61 | Q15012 | |
| DVFEDYIYGVTYINN | 4096 | Q07954 | |
| ERRNTGYQFIYYSPE | 391 | O15327 | |
| YPNREGAYQNREAVY | 116 | Q5JU85 | |
| FYYRARLQQEYAANG | 531 | O75387 | |
| DALSNYLGFNYEIYV | 476 | O43424 | |
| TYEVFTYSVRGLYEN | 3741 | Q96JB1 | |
| VRYYYVQNVYTPVDE | 506 | Q86TG7 | |
| EAVRALNVFYYLTYE | 2436 | P50851 | |
| LNVFYYLTYEGAVNL | 2441 | P50851 | |
| EEEYQAFLVYAAGVY | 86 | Q9NY33 | |
| FNVSRRFGYVAFQNY | 271 | P78334 | |
| YDQYLHRFAAYFQQG | 341 | P06744 | |
| YESQGLYRFANFVFI | 251 | Q9HB14 | |
| IYSVLGARETFENYY | 301 | Q9Y2D4 | |
| YVYELRQNLFVYNGT | 516 | Q9UKX5 | |
| YGTRIQQYFPSNYVE | 811 | P16885 | |
| YVTENNVPGAYIYAV | 471 | Q9P2E7 | |
| RYLGSVDYRYNNFFQ | 596 | Q86VP3 | |
| FYQYDVKSEIYSFGI | 386 | Q8NB16 | |
| NYELYYGFTRFAIEL | 821 | Q9BZF3 | |
| NYTVTEFQPLYYVAE | 376 | P00439 | |
| MQRYYVQYLSGFDAV | 426 | Q9Y2A7 | |
| YYTRAQFDLAFVVRY | 631 | Q02809 | |
| DLYIRAVNAEFIYGY | 1531 | Q9P2D7 | |
| AVNAEFIYGYEYLGN | 1536 | Q9P2D7 | |
| LVDGTYFIYSQVEVY | 296 | Q92838 | |
| QVEVYYINFTDFASY | 306 | Q92838 | |
| IIVYRASYFGAYDTV | 196 | Q9H0C2 | |
| YVANRYDYSVEFTGV | 196 | Q5T8I9 | |
| YYAQIRGFIQDQYCE | 166 | Q8WUU5 | |
| LQVYRDYYLTGDQNF | 626 | Q9HCG7 | |
| VYVYDSDQFVFGSYL | 196 | O43909 | |
| VYYRLPSYFQQAETV | 291 | Q86WZ0 | |
| IVGYQFIQTDNYYFS | 31 | Q92819 | |
| IYGYTFYSISQERFL | 71 | Q9Y2R0 | |
| YARYNSDLGEYQAVT | 66 | P13762 | |
| RYYFTVQSKDIFGRY | 651 | Q5U623 | |
| DFNGVELYALYDQFY | 306 | Q14314 | |
| YLYSSDAFLEGYVQQ | 1261 | Q76NI1 | |
| VYARYLVNEGFEYRL | 941 | P54198 | |
| KGYAYTFITEDQARY | 716 | Q7L014 | |
| SAYFVVSREYVGYVL | 286 | Q02742 | |
| LQAGSYVLRFYNTYS | 356 | B5MCN3 | |
| FYLEFGSAYTYIVQR | 546 | P46059 | |
| QRAIQVDPNYAYAYT | 591 | P30260 | |
| FRVQGDNYGFVTYRY | 1576 | Q5VV67 | |
| VGVIRYLGYFQAYNV | 391 | Q8IZK6 | |
| LRSQVYAVNGDYYVG | 26 | Q6PF18 | |
| FYYSRDYAQQIGVPE | 526 | Q9UKN5 | |
| VTNYYYGNSLVEFRN | 431 | Q68BL7 | |
| YGVFVSYIEIYNNYI | 216 | Q02241 | |
| NDTIVSAGEYTYYFR | 1246 | P11717 | |
| ASGSVRARYLVYFQY | 6 | Q8N0Z8 | |
| RARYLVYFQYVGTDF | 11 | Q8N0Z8 | |
| QGACVLYDNVVYRYL | 611 | Q9UIG8 | |
| FFTNDQYYVYFGTVR | 101 | Q9Y519 | |
| AYLYGRGVQVNYDLA | 456 | Q9UBV2 | |
| DYGFSFYIRYSEIIN | 1816 | B5MCY1 | |
| ARAAYIYIRGEFYNE | 151 | P49821 | |
| SGVNAIYYYADQIYL | 291 | P22732 | |
| FVEYYQYVDFHNQLG | 831 | P28715 | |
| RISVYYNEAYGRKYV | 46 | Q9H4B7 | |
| GVDANITRYFYEYDA | 2141 | Q9UKZ4 | |
| ITRYFYEYDADGQLQ | 2146 | Q9UKZ4 | |
| IFNVVYYEPLVYNNT | 536 | P48029 | |
| DFNYPDQYVREYAVG | 611 | P42338 | |
| ERIYVTNYYYGNTLV | 526 | Q68BL8 | |
| TNYYYGNTLVEFRNL | 531 | Q68BL8 | |
| YNGAFYYNRAFTRNI | 571 | Q68BL8 | |
| YANYFQTLIEVQAEY | 211 | Q17R89 | |
| VYDVRQAYVQFALSF | 191 | O60287 | |
| SYIGAFTYVFKYVEQ | 351 | Q9Y6L6 | |
| YYYLFQFSAALGQEV | 86 | Q8IWX5 | |
| EAYVQYREYMGFIQA | 216 | Q02040 | |
| LINYYQDRGYFEELI | 1286 | Q00610 | |
| NYLVFNDVDGLYTYT | 341 | Q8TBC4 | |
| FYYIQRFLYTGSQIG | 221 | Q8NC42 | |
| IYFVYSQVVFSGKAY | 106 | P01374 | |
| AEAELYQYYLAQNIG | 816 | Q86UP3 | |
| ALYYNTGRYEEALQI | 691 | Q8IUR5 | |
| VFLRSYYSVYDLGNN | 366 | P20142 | |
| YYSVYDLGNNRVGFA | 371 | P20142 | |
| LQYGYEYAFLVTASV | 201 | Q8NCC5 | |
| FYAYNFVRDVLQPYV | 226 | Q658P3 | |
| RINVYYNEASGGRYV | 46 | Q3ZCM7 | |
| RINVYYNEATGGNYV | 46 | P04350 | |
| GLAYAEYVIYRGEQA | 1286 | O95271 | |
| HQTGYFYFSYEVQRT | 61 | Q8WW62 | |
| HYFITELQYRNYGTQ | 386 | Q6P2S7 | |
| QYTVSLVTGDYLYNF | 1531 | Q9P273 | |
| IQYTAYGEIYFDSNI | 2316 | Q9P273 | |
| YQVLEYGEAVAQYTF | 451 | O60504 | |
| SAFVDVGLYQYRNVY | 471 | Q86WI1 | |
| LYYEAGQRFLEVQYL | 4516 | Q15149 | |
| VDYYEGGYRNQLYSR | 86 | Q96JE7 | |
| VEYYQSNYVFVFLGL | 71 | Q9UI14 | |
| NRTVVEEGYYYLNNF | 616 | Q9ULQ1 | |
| QYYTIYPQDNSAFVV | 181 | Q8WUU8 | |
| SRGEYVQAAPYYEQY | 606 | Q96AY4 | |
| VYHDSEEGQRYIQFY | 206 | O94888 | |
| AAQQGAFLREYLYVY | 636 | Q9Y2L5 | |
| HLYQYRVFGTYTDVT | 161 | Q9NQZ5 | |
| FANGLNQLYFYYETR | 531 | Q9UL62 | |
| GDVSRAAIQYINSYY | 1111 | Q70CQ2 | |
| YEQVSYNCFIAAGLY | 101 | Q6P5S7 | |
| SYKYFYVSAEQVVQG | 136 | O95881 | |
| LQYDFDTQYAFVGDY | 161 | Q8IWB7 | |
| AYILFYEQQGIDYAQ | 1361 | P35125 | |
| VLRAYNYVAQEVDDY | 551 | Q9NYU2 | |
| YYEQVDGVSYRKAIF | 196 | O14657 | |
| QKAAEGYTQFYYVDV | 5306 | Q9UKN1 | |
| NERNYHVFYYLLAGA | 331 | B2RTY4 | |
| LIVGNEYYFRVYTEN | 996 | Q14324 |